The event was attended by 500 students from Rayalaseema districts, Visakhapatnam, Guntur, Bapatla and the neighbouring states ...

Furthermore, Biocon has scheduled a board meeting on April 4 to discuss and approve fundraising for its commercial business ...

Biocon announced that its board is scheduled to meet on 4 April 2025 to consider raising funds through issuance of commercial papers (CP) or through any other mode via private placement basis.

Here's why one generic for Lipitor and other recognizable brands may have missed the mark compared to its recognizable ...

Analysts at Jefferies said that Indian pharmaceutical businesses, who depend heavily on the United States for their income, ...

Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an ...

The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...

Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.

Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...